Table 2.
Age at onset (y) (median [IQR]) (n = 63) | 8 (3, 16), range 0.58–50 |
Age at best reported bout (y) (median [IQR]) (n = 76) | 16 (8, 32), range 1–74 |
Sex (n = 84) | 53 (63%) female |
Cranial nerve(s) involved (n = 84) | 65 (77%) third |
1 (1%) fourth | |
13 (15%) sixth | |
5 (6%) multiple | |
Side (n = 69) | 32 (46%) left |
36 (52%) right | |
1 (1%) bilateral | |
Headache location (n = 53) | 30 (57%) peri-/retroorbital |
17 (32%) ipsilateral | |
6 (11%) other | |
Headache quality (n = 38) | 26 (68%) migrainous |
12 (32%) not migrainous | |
Interval from headache onset to ophthalmoplegia (d) (median [IQR], range [d]) (n = 54) | 1.6 (0.5, 3), range 0–14 |
Associated features | |
Photophobia (n = 40) | 26 (65%) |
Phonophobia (n = 25) | 14 (56%) |
Nausea (n = 38) | 25 (66%) |
Vomiting (n = 35) | 24 (69%) |
History of headaches (n = 41) | 34 (83%) |
Family history of headache (n = 47) | 29 (62%) |
Cerebrospinal fluid findings (n = 32) | 30 normal (94%), 1 case had IgG index 0.87 and 1 had a single oligoclonal band |
Vascular imaging (n = 42) | 16 (38%) conventional angiography |
24 (57%) MR angiography | |
2 (5%) CT angiography | |
Normal in 39 (93%) | |
Steroid response (n = 26) | 54% (14) beneficial |
8% (2) not beneficial | |
4% (1) worsened | |
35% (9) unclear whether beneficial | |
Persistent findings (n = 35) | 19 (54%) |
Subgroup analysis of those who had third nerve involvement and had an MRI with gadolinium during an acute attack (n = 52) | |
Nerve root thickening (n = 50) | 38 (76%) |
Nerve root enhancement (n = 52) | 39 (75%) |
Abbreviations: CT, computed tomographic; IQR, interquartile range; MR, magnetic resonance; MRI, magnetic resonance imaging.